1-165563796-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001005214.4(LRRC52):c.914C>T(p.Ser305Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000333 in 1,614,144 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001005214.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LRRC52 | NM_001005214.4 | c.914C>T | p.Ser305Leu | missense_variant | 2/2 | ENST00000294818.2 | |
LRRC52-AS1 | NR_026744.2 | n.959+10222G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LRRC52 | ENST00000294818.2 | c.914C>T | p.Ser305Leu | missense_variant | 2/2 | 1 | NM_001005214.4 | P1 | |
LRRC52-AS1 | ENST00000416424.5 | n.872+10222G>A | intron_variant, non_coding_transcript_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152160Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000227 AC: 57AN: 251296Hom.: 0 AF XY: 0.000265 AC XY: 36AN XY: 135842
GnomAD4 exome AF: 0.000348 AC: 509AN: 1461866Hom.: 0 Cov.: 34 AF XY: 0.000364 AC XY: 265AN XY: 727234
GnomAD4 genome AF: 0.000190 AC: 29AN: 152278Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.914C>T (p.S305L) alteration is located in exon 2 (coding exon 2) of the LRRC52 gene. This alteration results from a C to T substitution at nucleotide position 914, causing the serine (S) at amino acid position 305 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at